These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 39380010

  • 1. HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression.
    Rong S, Dai B, Yang C, Lan Z, Wang L, Xu L, Chen W, Chen J, Wu Z.
    J Transl Med; 2024 Oct 08; 22(1):914. PubMed ID: 39380010
    [Abstract] [Full Text] [Related]

  • 2. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
    Shen J, Ma Z, Yang J, Qu T, Xia Y, Xu Y, Zhou M, Liu W.
    BMC Cancer; 2024 Apr 23; 24(1):511. PubMed ID: 38654205
    [Abstract] [Full Text] [Related]

  • 3. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S, Chen W, Wang J, Qi L, Pan H, Feng Z, Tian D.
    Theranostics; 2021 Apr 23; 11(7):3359-3375. PubMed ID: 33537092
    [Abstract] [Full Text] [Related]

  • 4. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.
    Chen Z, Zhong X, Xia M, Liu C, Tang W, Liu G, Yi Y, Guo Y, Jiang Q, Zu X, Zhong J.
    Cell Death Dis; 2024 Oct 08; 15(10):733. PubMed ID: 39379360
    [Abstract] [Full Text] [Related]

  • 5. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
    Yadav S, Bhagat SD, Gupta A, Samaiya A, Srivastava A, Shukla S.
    BMC Cancer; 2019 Nov 01; 19(1):1031. PubMed ID: 31675998
    [Abstract] [Full Text] [Related]

  • 6. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.
    Liu YY, Xia M, Chen ZB, Liao YD, Zhang CY, Yuan L, Pan YW, Huang H, Lu HW, Yao SZ.
    Cell Death Dis; 2024 Oct 07; 15(10):732. PubMed ID: 39375330
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y, Qin J, He Z, Cui G, Zhang K, Wu B.
    Genes Genomics; 2021 Feb 07; 43(2):141-150. PubMed ID: 33481227
    [Abstract] [Full Text] [Related]

  • 8. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, Hu Q, Liu N, You Y.
    Oncotarget; 2015 May 30; 6(15):13006-18. PubMed ID: 25948776
    [Abstract] [Full Text] [Related]

  • 9. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 10. CCT2 Regulates ZEB1-Induced EMT Gene Transcription to Promote the Metastasis and Tumorigenesis of Papillary Thyroid Carcinoma.
    Liu W, Lin R, Zhu C, Chen Y, Gao Q, Zhong J.
    Discov Med; 2024 Sep 22; 36(188):1819-1830. PubMed ID: 39327245
    [Abstract] [Full Text] [Related]

  • 11. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
    Feng C, Gao Y, Wang C, Yu X, Zhang W, Guan H, Shan Z, Teng W.
    J Clin Endocrinol Metab; 2013 Sep 22; 98(9):E1524-33. PubMed ID: 23846818
    [Abstract] [Full Text] [Related]

  • 12. m6A RNA methylation regulators have prognostic value in papillary thyroid carcinoma.
    Hou J, Shan H, Zhang Y, Fan Y, Wu B.
    Am J Otolaryngol; 2020 Sep 22; 41(4):102547. PubMed ID: 32474328
    [Abstract] [Full Text] [Related]

  • 13. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
    Chen JJ, Lu TZ, Wang T, Yan WH, Zhong FY, Qu XH, Gong XC, Li JG, Tou FF, Jiang LP, Han XJ.
    Cell Death Dis; 2024 Jun 03; 15(6):390. PubMed ID: 38830885
    [Abstract] [Full Text] [Related]

  • 14. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.
    Xie R, Chen W, Lv Y, Xu D, Huang D, Zhou T, Zhang S, Xiong C, Yu J.
    J Formos Med Assoc; 2023 Aug 03; 122(8):738-746. PubMed ID: 36739231
    [Abstract] [Full Text] [Related]

  • 15. HNRNPC impedes m6A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma.
    Huang XT, Li JH, Zhu XX, Huang CS, Gao ZX, Xu QC, Zhao W, Yin XY.
    Cancer Lett; 2021 Oct 10; 518():196-206. PubMed ID: 34271104
    [Abstract] [Full Text] [Related]

  • 16. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F, Guan Y, Ma Y, Xue L, Zhang P, Yang X, Chong T.
    Aging (Albany NY); 2021 Apr 21; 13(8):11919-11941. PubMed ID: 33952721
    [Abstract] [Full Text] [Related]

  • 17. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M, Zhu Y, Chen Z, Lin S, Peng X, Luo D, Li H, Tan L.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32303750
    [Abstract] [Full Text] [Related]

  • 18. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y, Chen G, Wang B, Wu H, Zhang Y, Ye H.
    Endocr J; 2021 Jun 28; 68(6):713-727. PubMed ID: 33716239
    [Abstract] [Full Text] [Related]

  • 19. The splicing factor QKI inhibits metastasis by modulating alternative splicing of E-Syt2 in papillary thyroid carcinoma.
    Zhao M, Jin Y, Yan Z, He C, You W, Zhu Z, Wang R, Chen Y, Luo J, Zhang Y, Yao Y.
    Cancer Lett; 2024 Nov 01; 604():217270. PubMed ID: 39306227
    [Abstract] [Full Text] [Related]

  • 20. HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA.
    Wang JM, Jiang JY, Zhang DL, Du X, Wu T, Du ZX.
    J Cell Mol Med; 2021 May 01; 25(10):4814-4825. PubMed ID: 33792181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.